Pautas

Cards

  • Publicado en

    American Diabetes Association   Cuidado de la diabetes, 2020  Las normas de asistencia médica para la diabetes de la American Diabetes Association (ADA) describen las recomendaciones actuales de la práctica clínica para la atención de la diabetes, incluidos los objetivos de tratamiento, las herramientas para evaluar la calidad de la atención y las recomendaciones para el control del lipidograma (que se puede realizar a través del anál...

    Enfermedades cardiovasculares y gestión del riesgo: normas de asistencia médica para la diabetes - 2020

    en
    fr
    es
    pt
    it
    Acceder ya
    Contenido Certificado
    Restricted
  • Publicado en

    This updated guidance from the Infectious Diseases Society of America (IDSA) aims to provide an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of COVID-19 molecular diagnostic testing.

    IDSA guidelines on the diagnosis of COVID-19 molecular diagnostic testing

    en
    Acceder ya
  • Publicado en

    The International Diabetes Federation (IDF) published an updated version of its flagship ‘Diabetes Atlas’ in 2019. The atlas covers evidence on the impact of diabetes worldwide, including recommendations for testing and screening.

    IDF testing and screening recommendations for diabetes from the 2019 Diabetes Atlas

    en
    Acceder ya
  • Publicado en

    This clinical practice guideline from the American Heart Association (AHA) aims to give healthcare providers consistent, clear, and evidence-based guidance for treating patients at risk for atherosclerotic cardiovascular disease (ASCVD)

    AHA cholesterol management guideline for healthcare practitioners

    en
    Acceder ya
  • Publicado en

    The guideline focusses on how clinicians can get the most efficacy and highest quality results from implementing best practices for POCT. The authors state that a quality assurance program is vital to managing reliability of POCT results.

    AACC guidance on the management of point-of-care testing

    en
    Acceder ya
  • Publicado en

    This clinical practice guideline from the American College of cardiology (ACC) and American Heart Association (AHA) provides recommendations applicable to patients with or at risk of developing cardiovascular disease (CVD).

    ACC / AHA guideline on the primary prevention of cardiovascular disease

    en
    Acceder ya
  • Publicado en

    This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.

    IDSA clinical practice guideline update on the management of seasonal influenza

    en
    Acceder ya
  • Publicado en

    Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.

    Tackling drug-resistant infections globally: report and recommendations

    en
    Acceder ya
  • Publicado en

    The objective of these guidelines from the World Health Organization (WHO) is to provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings.

    WHO guidelines on second-and third-line medicines and type of insulin for blood glucose control in diabetes

    en
    Acceder ya
  • Publicado en

    The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease (CKD) represents an update to the 2012 KDIGO guideline.

    KDIGO clinical practice guidelines for the management of blood pressure in chronic kidney disease

    en
    Acceder ya
  • Publicado en

    The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

    en
    Acceder ya
    Contenido Certificado
    Restricted
  • Publicado en

    The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) European Heart Journal 2020;42:255-323

    2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    en
    Acceder ya
    Contenido Certificado
    Restricted

No hay más resultados